Last updated: 2026-10-14 22:46:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Caris Life Sciences, Inc. (CAI) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $30.25, with a market capitalization of $8.39B and a P/E ratio of 79.37. Over the past 52 weeks, its price has ranged from $14.19 to $33.65. This page covers its latest market performance, valuation, price trends and company information.
$8.39B | |
$29.23 | |
$69.18 | |
$4.83 | |
$29.53 | |
3.90M | |
4.97M | |
79.37 | |
$33.65 | |
$14.19 | |
-- | |
-- |
Caris Life Sciences, Inc. (CAI) is trading at $30.54 in after-hours trading as of 2026-10-14 22:42:00, up 3.40% ($1.00) from the regular-session close of $29.53.
After-hours trading shows how investors are pricing CAI after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Caris Life Sciences, Inc. (CAI) moved from $30.39 to $30.25, representing a decline of 0.47% ($0.14).
The stock traded between $25.87 and $32.56 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 4.57 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 82.5%
CAI is currently trading at $30.25, placing it 82.5% of the way from its 52-week low of $14.19 to its 52-week high of $33.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 1846 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Caris Life Sciences, Inc. (CAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.